These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 23956224)

  • 1. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
    Ho PA; Alonzo TA; Gerbing RB; Kuhn J; Pollard JA; Hirsch B; Raimondi SC; Gamis AS; Meshinchi S
    Pediatr Blood Cancer; 2014 Jan; 61(1):81-8. PubMed ID: 23956224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
    Ho PA; Kuhn J; Gerbing RB; Pollard JA; Zeng R; Miller KL; Heerema NA; Raimondi SC; Hirsch BA; Franklin JL; Lange B; Gamis AS; Alonzo TA; Meshinchi S
    J Clin Oncol; 2011 Feb; 29(6):704-11. PubMed ID: 21189390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia.
    Junghanns AS; Wittig S; Woehlecke C; Lehmann T; Arndt C; Gruhn B
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2221-8. PubMed ID: 26224397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Prognostic Impact of Wilms' Tumor 1 (WT1) Gene, Including SNP rs16754 in Cytogenetically Normal Acute Myeloblastic Leukemia (CN-AML): An Iranian Experience.
    Toogeh G; Ramzi M; Faranoush M; Amirizadeh N; Haghpanah S; Moghadam M; Cohan N
    Clin Lymphoma Myeloma Leuk; 2016 Mar; 16(3):e21-6. PubMed ID: 26725263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
    Damm F; Heuser M; Morgan M; Yun H; Grosshennig A; Göhring G; Schlegelberger B; Döhner K; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar A; Fiedler W; Kirchner H; Döhner H; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 Feb; 28(4):578-85. PubMed ID: 20038731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.
    Becker H; Maharry K; Radmacher MD; Mrózek K; Metzeler KH; Whitman SP; Schwind S; Kohlschmidt J; Wu YZ; Powell BL; Carter TH; Kolitz JE; Wetzler M; Carroll AJ; Baer MR; Moore JO; Caligiuri MA; Larson RA; Marcucci G; Bloomfield CD
    Haematologica; 2011 Oct; 96(10):1488-95. PubMed ID: 21659357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism of Wilms' tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia.
    Choi Y; Lee JH; Hur EH; Kang MJ; Kim SD; Lee JH; Kim DY; Lim SN; Bae KS; Lim HS; Seol M; Kang YA; Lee KH
    Ann Hematol; 2012 May; 91(5):671-677. PubMed ID: 22015946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of The Wilms' Tumor-1 (WT1) rs16754 polymorphism in acute myeloid leukemia.
    Petiti J; Rosso V; Lo Iacono M; Calabrese C; Signorino E; Gaidano V; Berger M; Saglio G; Cilloni D
    Leuk Res; 2018 Apr; 67():6-11. PubMed ID: 29407184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1 mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population.
    Chen X; Yang Y; Huang Y; Tan J; Chen Y; Yang J; Dou H; Zou L; Yu J; Bao L
    Leuk Lymphoma; 2012 Nov; 53(11):2195-204. PubMed ID: 22506617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms Tumor 1 Expression at Diagnosis Correlates With Genetic Abnormalities and Polymorphism But Is Not Independently Prognostic in Acute Myelogenous Leukemia: A Hokkaido Leukemia Net Study.
    Hidaka D; Onozawa M; Hashiguchi J; Miyashita N; Kasahara K; Fujisawa S; Hayase E; Okada K; Shiratori S; Goto H; Sugita J; Nakagawa M; Hashimoto D; Kahata K; Endo T; Yamamoto S; Tsutsumi Y; Haseyama Y; Nagashima T; Mori A; Ota S; Sakai H; Ishihara T; Imai K; Miyagishima T; Kakinoki Y; Kurosawa M; Kobayashi H; Iwasaki H; Shimizu C; Kondo T; Teshima T
    Clin Lymphoma Myeloma Leuk; 2018 Nov; 18(11):e469-e479. PubMed ID: 30082223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
    Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
    J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia.
    Luo S; Yu K; Yan QX; Shen ZJ; Wu JB; Chen HM; Gao SM
    Leuk Lymphoma; 2014 Feb; 55(2):349-57. PubMed ID: 23550990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Wilms Tumor-1 (WT1) rs16754 polymorphism is a prognostic factor in acute myeloid leukemia (AML): a meta-analysis.
    Long J; Fang S; Dai Q; Liu X; Zhu W; Wang S
    Oncotarget; 2016 May; 7(22):32079-87. PubMed ID: 26992216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the Wilms tumor-1 rs16754 polymorphism and acute myeloid leukemia: A MOOSE-compliant meta-analysis.
    Yu X; Zhang Y; Liu S; Mu Y; Shang F; Zhang N
    Medicine (Baltimore); 2020 Jul; 99(27):e20713. PubMed ID: 32629644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms in the Wilms' tumour gene 1 in clear cell renal cell carcinoma.
    Li X; Wang S; Sitaram RT; Andersson C; Ljungberg B; Li A
    PLoS One; 2013; 8(3):e58396. PubMed ID: 23484026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms Tumor 1 rs16754 predicts favorable clinical outcomes for acute myeloid leukemia patients in South Chinese population.
    Zhang DY; Yan H; Cao S; Zhang W; Li XL; Zeng H; Chen XP
    Leuk Res; 2015 Jun; 39(6):568-74. PubMed ID: 25841655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia.
    Niavarani A; Horswell S; Sadri R; Bonnet D
    Ann Hematol; 2016 Jan; 95(2):179-90. PubMed ID: 26499507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High WT1 mRNA expression after induction chemotherapy and FLT3-ITD have prognostic impact in pediatric acute myeloid leukemia: a study of the Japanese Childhood AML Cooperative Study Group.
    Shimada A; Taki T; Koga D; Tabuchi K; Tawa A; Hanada R; Tsuchida M; Horibe K; Tsukimoto I; Adachi S; Kojima S; Hayashi Y
    Int J Hematol; 2012 Oct; 96(4):469-76. PubMed ID: 22915059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
    Ho PA; Zeng R; Alonzo TA; Gerbing RB; Miller KL; Pollard JA; Stirewalt DL; Heerema NA; Raimondi SC; Hirsch B; Franklin JL; Lange B; Meshinchi S
    Blood; 2010 Aug; 116(5):702-10. PubMed ID: 20413658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
    Pollard JA; Alonzo TA; Loken M; Gerbing RB; Ho PA; Bernstein ID; Raimondi SC; Hirsch B; Franklin J; Walter RB; Gamis A; Meshinchi S
    Blood; 2012 Apr; 119(16):3705-11. PubMed ID: 22378848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.